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Althoughfearoffalling(FOF)iscommoninpeoplewithParkinson’sdisease(PD),thereisalackofresearchinvestigatingpotential
predictors of FOF. This study explored the impact of motor, nonmotor, and demographic factors as well as complications of drug
therapy on FOF among people with PD. Postal survey data (including the Falls Eﬃcacy Scale, FES) from 154 nondemented people
with PD were analyzed using multiple regression analyses. Five signiﬁcant independent variables were identiﬁed explaining 74%
of the variance in FES scores. The strongest contributing factor to FOF was walking diﬃculties (explaining 68%), followed by
fatigue,turninghesitations,needforhelpindailyactivities,andmotorﬂuctuations.Exploringspeciﬁcaspectsofwalkingidentiﬁed
three signiﬁcant variables explaining 59% of FOF: balance problems, limited ability to climb stairs, and turning hesitations. These
results have implications for rehabilitation clinicians and suggest that walking ability is the primary target in order to reduce FOF.
Speciﬁcally, balance, climbing stairs, and turning seem to be of particular importance.
1.Introduction
People with Parkinson’s disease (PD) have an increased risk
of falling [1], and fear of falling (FOF) is also more common
and pronounced compared to controls [2–6]. FOF has been
described as an ongoing concern about falling, a loss of bal-
ance conﬁdence, low fall-related self-eﬃcacy, or as activity
avoidance [7–11].
The prevalence of FOF in people with PD has been
reported to range from 35% to 59% [2, 12–16], although a
study that included only men reported a lower prevalence
(18%)[17].Itisevenmorecommonandpronouncedamong
fallers [2, 6, 12–14, 17–19]. FOF can cause social isolation
[20], and up to 70% of people with PD report activity
limitations due to FOF [2, 21]. It is thus important for reha-
bilitation clinicians to understand the factors contributing to
FOF.
Successful interventions need to be based on an under-
standing of factors associated with (and potentially inﬂuenc-
ing) the target of the intervention. That is, if rehabilitation
aims to reduce FOF, it should target factors that may inﬂu-
ence FOF. With respect to FOF in PD, weak to moderate
associations (Spearman correlations (rs)) have been found
between FOF and age (rs, ≤ 0.08), PD duration (rs, <0.29),
and disease severity (rs, 0.47) [14, 22]. Previous studies
have also shown that FOF relates to freezing of gait (FOG)
[15, 23], physical functioning [14], gait tests [5, 14, 22, 24],
balance [3, 14, 22], mobility, activities of daily living (ADL)
[14, 21], and sex [14]. However, those studies have relied
on bivariate analyses, and none has simultaneously taken a
broader range of independent variables (e.g., motor symp-
toms,drugtherapycomplicationssuchasmotorﬂuctuations
and dyskinesias, nonmotor symptoms, and demographic
factors) into account. The objective of this study was to2 Parkinson’s Disease
explore the potential contributions of motor, nonmotor, and
demographic factors, as well as complications of drug ther-
apy, on FOF among people with PD.
2.ParticipantsandMethods
Data were collected by a postal survey to a sample of peo-
ple with idiopathic PD [25]. All individuals with PD that
receivedcareataSwedishuniversityhospitalwereconsidered
for inclusion in the study. Exclusion criteria constituted
dementia or severe cognitive impairment as determined by
their respective PD-specialized nurse clinicians. The survey
was sent to 282 individuals (39% women) followed by a re-
minder about ten days later. Of 231 returned questionnaires,
38 were returned blank and two were returned to sender
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respondents (43% women; conservative total response rate,
68%). Six of these had left the included FOF-questionnaire
completely blank, and total scores could not be computed
for another 31 participants due to missing data. These 37
persons were excluded from the analysis. Excluded partici-
pants did not diﬀer (P ≥ 0.153) from those included with
respect to sex, age, and PD duration. Characteristics of the
ﬁnal study sample (n = 154) are presented in Table 1.T h e
investigators did not have access to patient details (beyond
those provided by survey responders) or addresses. The
study was conducted in accordance with the Declaration of
Helsinki, and all participants gave their informed consent.
2.1. Survey Questions and Instruments. In addition to demo-
graphic questions, the survey included a set of questions on
the presence or absence (no/yes) of motor ﬂuctuations (i.e.,
a ﬂuctuating eﬀect of anti-PD medications with periods of
more severe motor symptoms), dyskinesias (i.e., involuntary,
irregular, twisting, and/or jerky movements), comorbidity,
FOF, falls during the past six months (described and deﬁned
as by Lamb et al. [26]), near falls (described and deﬁned
as by Gray and Hildebrand [27]), and need of help from
others in daily activities. Overall perceived PD severity was
self-rated as “mild,” “moderate,” or “severe.” In addition,
participants were asked whether they had responded to the
survey themselves (with or without assistance in reading
and/or writing).
A battery of self-administered questionnaires was in-
cluded. The Falls Eﬃcacy Scale (FES) conceptualizes FOF as
lowfall-relatedself-eﬃcacy[8].TheSwedishversion,FES(S),
includes 13 items (activities) rated from 0 (not con-ﬁdent
at all) to 10 (completely conﬁdent) [14, 28]. The maximum
total score is 130 points, and a higher score denotes “better”
balance conﬁdence. The Functional Assessment of Chronic
Illness Therapy-Fatigue scale (FACIT-F) consists of 13 items
with a total score ranging between 0–52 (higher scores = less
fatigue) [29, 30]. The physical functioning (PF) scale from
the Short Form-36 (SF-36) includes ten items, and the total
score can range between 0–100 (higher scores = better) [31,
32].Theself-administeredversionoftheFOGQuestionnaire
(FOGQsa) consists of six items graded 0–4 (higher = worse)
[15]. In this study we only used items 3 (freezing: “Do you
feel that your feet get glued to the ﬂoor while walking, making
a turn or when trying to initiate walking (freezing)?”)a n d6
(turning hesitations: “During the past week, how long have
your typical “freezing” episodes been when making a turn?”)o f
the FOGQsa. Those scoring ≥1 on item 3 were categorized as
“freezers,”andthosescoring ≥1onitem6wereconsideredto
have turning hesitations. The generic version of the Walk-12
(Walk-12G) assesseswalking diﬃculties in everydaylifefrom
the individual’s perspective [33–35]. The total Walk-12G
score ranges between 0–42 points (higher scores = worse). In
this study, item 6 (“ H a v ey o uh a dp r o b l e m sb a l a n c i n gw h e n
standing or walking?”) of the Walk-12G (graded 0–4) was
speciﬁcally used to identify and describe balance problems.
Those scoring ≥1 were considered having balance problems.
The pain section of the Nottingham Health Proﬁle (NHP-
Pain) has eight items and yields a total score between 0–100
(higher scores = more pain) [36, 37].
All included patient-reported rating scales have previ-
ously been found to have acceptable validity and reliability
in people with PD [14, 15, 30, 32, 35, 37]. Reliabilities
(coeﬃcient alpha) in this study were as follows: FES(S), 0.98;
FACIT-F, 0.85; PF, 0.93; Walk-12G, 0.96; NHP-Pain, 0.85.
Correcteditem-totalcorrelationsinthisstudywereall ≥0.30.
Thesedatasupporttheadequaciesofscoresusedinthisstudy
[38].
2.2. Statistical Analysis. Data were checked regarding under-
lying assumptions and described and analyzed accordingly
using PASW version 18 (SPSS Inc., Chicago, IL). The alpha
level of signiﬁcance was set at 0.05 (2-tailed, exact P-values
were used).
Spearman correlations (rs) and Mann-Whitney U-tests
were used for bivariate analyses of associations with FOF,
that is, FES(S). Variables signiﬁcantly associated with FES(S)
scores in bivariate analyses were then entered as independent
variables in regression models with FES(S) scores as the
dependent variable. To ease interpretation, all scores were
adjusted to be in the same direction (higher scores = more
problems) before being entered into the regression analyses.
A ﬁrst regression model (method: forward) included
motor, nonmotor, and demographic factors as well as drug
therapy complications (i.e., ﬂuctuations and dyskinesias) as
independent variables. Further details about the included
independent variables are provided as footnotes in Table 2.
Based on results from the ﬁrst model, a second model was
explored (method: enter with manual backward deletion)
consisting of items from scales found signiﬁcant in the ﬁrst
model. These items (independent variables) were select-
ed based on whether they appeared to represent speciﬁc
aspects potentially suitable for rehabilitation interventions,
in combination with clinical considerations. Details about
the included independent variables are provided as footnotes
in Table 3.
3. Results
Eighty-ﬁve % (131/154) of the participants responded
completely independently to the postal survey, whereas theParkinson’s Disease 3
Table 1: Sample characteristics and bivariate associations with FES(S) scores (n = 154).
Total sample Spearman correlations with FES(S) scores P value
Mean (SD) age, years 70 (9.1) −0.24 0.003
Mean (SD) PD duration, years 6 (5.4) −0.42 <0.001
Fatigue (FACIT-F), median (q1–q3) 36 (27–42) 0.67 <0.001
Physical function (PF), median (q1–q3) 65 (40–84) 0.79 <0.001
Pain (NHP), median (q1–q3) 0 (0–25) −0.50 <0.001
Walk-12G, median (q1–q3) 13 (6–23) −0.82 <0.001
n/total % Median (q1–q3) FES(S) scores P-valuea
Dichotomous variables No Yes
Education: university degree 37/153 24 115 (69–130) 112 (70–130) 0.941
Living alone 38/150 25 119 (80–130) 96 (55–130) 0.125
Comorbidity 77/142 50 107 (60–130) 120 (74–130) 0.271
Motor ﬂuctuations 90/152 58 124 (86–130) 104 (64–128) 0.010
Dyskinesia 57/153 37 124 (85–130) 93 (53–117) <0.001
Freezing of gaitb 57/152 37 128 (112–130) 69 (47–101) <0.001
Turning hesitationsc 58/150 38 128 (113–130) 69 (48–102) <0.001
Experienced falls 50/149 33 123 (90–130) 81 (44–113) <0.001
Experienced near falls 69/147 45 129 (111–130) 84 (52–115) <0.001
Needing help from others in daily
activities 42/153 27 124 (104–130) 59 (35–91) <0.001
Sex, women 62/152 41 Women
116 (52–130)
Men
112 (77–130) 0.407
Possible score ranges: FACIT-F, 0–52 (higher = better); PF, 0–100 (higher = better); NHP-Pain, 0–100 (higher = worse); Walk-12G, 0–42 (higher = worse);
FES(S), 0–130 (higher = better).
aMann Whitney U-test.
bAs assessed by item 3 (“freezing”) of the FOGQsa (Freezing of Gait Questionnaire, self-administered version). Those scoring ≥1 were categorized as freezers.
cAs assessed by item 6 (“turning hesitations”) of the FOGQsa. Those scoring ≥1 were categorized as having turning hesitations.
FACIT-F: the Functional Assessment of Chronic Illness Therapy-Fatigue scale; FES(S): the Swedish version of the Falls Eﬃcacy Scale; NHP: the Nottingham
Health Proﬁle; PD: Parkinson’s disease; SD: standard deviation; q1–q3: ﬁrst and third quartiles.
Table 2: Multiple linear regression with fear of falling (FES(S) scores) as the dependent variable among people with Parkinson’s diseasea,b.
Signiﬁcant independent variablesc B (95% CI) β P-value Adjusted R2
Stepwise change Cumulative
Walking diﬃculties (Walk 12-G) 1.7 (1.2, 2.2) 0.55 <0.001 0.680 0.680
Fatigue (FACIT-F) 0.74 (0.26, 1.2) 0.22 0.003 0.023 0.703
Turning hesitations (item 6, FOGQsa) 11 (2.5, 19.6) 0.15 0.012 0.014 0.717
Need help from others in daily activities 10 (0.96, 19) 0.13 0.030 0.010 0.727
Fluctuations −7.6 (−15, −0.48) −0.11 0.037 0.008 0.735
aFor the regression analysis, scores were adjusted to be in the same direction: higher scores = more problems.
bIndependent variables in the analysis were fatigue (FACIT-F), age (years), PD-duration (years), pain (NHP), turning hesitations (item 6, FOGQsa:
dichotomized, 1 = turning hesitations), ﬂuctuations (1 = yes), dyskinesia (1 = yes), freezing (item 3, FOGQsa: dichotomized, 1 = freezing), falls (1 = yes), near
falls (1 = yes), need help from others in daily activities (1 = yes), and walking diﬃculties (Walk12-G).
cListed by order of entry into the model (forward method).
B: regression coeﬃcient; CI: conﬁdence interval; β: standardized regression coeﬃcient.
rest attained assistance in reading or writing. The included
154 participants had a median FES(S) score of 114 (q1–q3,
69–130; min-max, 0–130) and 29% scored at maximum,
that is, 130. According to the dichotomous FOF-question,
45% (67 out of 149) perceived themselves as having FOF.
In addition, 76% (112/148) of the participants experienced
balance problems when standing or walking. Perceived PD
severity was rated as “moderate” by 96 participants and
ranged from “mild” (n = 43) to “severe” (n = 14).
Bivariate analyses are presented in Table 1.F E S ( S )s c o r e s
demonstrated the weakest correlation with age (rs, −0.24)
and the strongest (rs, −0.82) with walking diﬃculties. Those
reporting the presence of motor ﬂuctuations and dyskinesias
had signiﬁcantly (P ≤ 0.010) lower FES scores (i.e., more
FOF) than those who did not (Table 1). Needing help from
others in daily activities and experiencing FOG, turning
hesitations, prior falls or near falls were also associated with
more (P<0.001) FOF (Table 1).4 Parkinson’s Disease
Table 3: Explorative multiple linear regression with fear of falling (FES(S) scores) as the dependent variable among people with Parkinson’s
diseasea,b.
Adjusted R2:0 . 5 9 B (95% CI) β P-value
Independent variables
Balance problems (item 6, Walk-12G)
Not at all Reference category
A little 3.6 (−6.3, 13) 0.05 0.474
Moderately-extremely 26 (14, 38) 0.36 <0.001
Limited ability to climb stairs (item 5, Walk-12G)
Not at all Reference category
A little 6.8 (−3.4, 17) 0.084 0.188
Moderately-extremely 27 (16, 37) 0.37 <0.001
Turning hesitations (item 6, FOGQsa) 21 (12, 30) 0.29 <0.001
aFor the regression analysis, FES(S) scores (range, 0–130) were reversed (0 = better).
bIndependent variables (method: enter with manual backward deletion) were: “Have you been limited in your ability to climb up and down stairs?” (item 5,
Walk-12G), “Have you had problems balancing when standing or walking?” (item 6, Walk-12G), “Have you been limited in how far you are able to walk?”
(item 11, Walk-12G), turning hesitations (item 6, FOGQsa), and “Has your walking been slow?” (item 12, Walk-12G).
The original ﬁve response categories of Walk-12G were recoded before being entered in the model: “not at all,” “a little,” or “moderately-quite a bit-extremely.”
B, regression coeﬃcient; CI, conﬁdence interval; β, standardized regression coeﬃcient.
In the ﬁrst regression model, there were signs of mul-
ticollinearity between PF and Walk-12G scores (data not
shown). PF was therefore omitted from the model in
favor of the Walk-12G. This was done because the Walk-
12G represents a more speciﬁc variable and exhibited a
somewhat better reliability than the PF (0.96 versus 0.93).
This resulted in a model with ﬁve signiﬁcant independent
variables, explaining 74% of the variance in FES(S) scores
(Table 2). The strongest independent variable (as assessed
by the standardized regression coeﬃcients, β) was walking
diﬃculties, which alone explained 68% of the variance
in FES(S) scores. This was followed by fatigue, turning
hesitations, needing help from others in daily activities, and
motor ﬂuctuations (Table 2).
In the second explorative regression model, speciﬁc gait
and balance items were entered as independent variables
(Table 3). In this model, the original ﬁve response categories
of Walk-12G items were recoded and entered as dummy
variables: “not at all” (reference category), “a little,” and
“moderately/quiete a bit/extremely,” that is, the three worst
categories were merged into one (due to skewed response
distributions). Two Walk-12G items were omitted from the
model: item 11 (“Have you been limited in how far you are
able to walk?”) due to signs of multicollinearity and item 12
(“Has your walking been slow?”) which was not signiﬁcant.
The ﬁnal model included three signiﬁcant independent
variables explaining 59% of the variance in FES(S) scores
(Table 3). The two strongest independent variables were
(moderate to extreme) limitations in climbing stairs and
balanceproblems.Thethirdsigniﬁcantindependent variable
was turning hesitations.
4. Discussion
This study identiﬁed that walking disabilities contributed
the strongest to FOF (i.e., low fall-related self-eﬃcacy) in
people with PD. That is, variations in self-rated walking
ability could account for a high proportion (68%) of the
varianceinFES(S)scores.Thisisinlinewithpreviousstudies
showing arelationship between FOFand clinical gaittests [5,
14, 22, 24]. Furthermore, a mixed method pilot study found
that FOF was universally reported in connection to everyday
walking [39]. Our results have important implications for
rehabilitation and suggest that walking diﬃculties should
be the main target in order to reduce FOF. Arguably, such
interventions may beneﬁt from speciﬁcally targeting balance
problems, stair climbing, and turning hesitations. These
issues are of particular relevance for the physical therapist
within the interdisciplinary team.
The present ﬁnding of balance problems contributing
independently to FOF is in accordance with previous results
based on bivariate analyses [3, 14, 22]. It is noteworthy
that prior falls or near falls were not independently asso-
ciated to FOF when controlling for the other independent
variables, despite the highly signiﬁcant bivariate relationship
demonstrated. This ﬁnding illustrates a major pitfall in re-
lying on bivariate analyses. However, we did not register
falls prospectively (as has been recommended [26]), and
our sample had a relatively low proportion of fallers. Still,
although further conﬁrmatory studies are needed, our ﬁnd-
ings suggest that focus primarily should be put on perceived
balance impairment rather than on fall prevention per se in
order to reduce FOF.
Impaired balance is common among people with PD,
which is conﬁrmed by the fact that 76% of the participants
in our study reported balance problems. This corresponds to
the ﬁnding of Schrag et al., who reported that 65% of peo-
ple with a PD duration of ﬁve years or more experience a
postural instability [40]. Although gait and balance training
are common in rehabilitation for people with PD, very
few studies have investigated the eﬀects on FOF. Some stu-
dies reported improvements after training [41–44], but it
is unclear whether these were of clinical signiﬁcance. InParkinson’s Disease 5
addition, none of these studies included a long-term fol-
lowup and all used diﬀerent outcome measures, which limit
their comparability. Further studies are therefore warranted,
which are of importance since pharmacological treatments
have insuﬃcient eﬀects on gait and balance problems [45–
47]. In addition, although deep brain stimulation in the
subthalamic nuclei has been shown to positively inﬂuence
FOF [48, 49], it is a surgical option only eligible for a
minority of people with PD.
We identiﬁed turning hesitations to be independently
associated with FOF. While turning hesitations are related to
FOG, it is noteworthy that freezing was not associated with
FOF when controlling for the other independent variables in
the identiﬁed model, despite the highly signiﬁcant bivariate
relationship demonstrated between FOF and FOG. This
further illustrates the pitfall in relying on bivariate analyses.
The present results suggest that turning hesitations should
be more speciﬁcally addressed than FOG per se in order to
reduce FOF. Turning is in fact impaired in mild PD [50],
and rehabilitation clinicians (such as physical therapists)
should therefore consider this already early on. Furthermore,
moderate to extreme limitations in climbing stairs were also
independently associated with FOF, and a previous study
showed that stairs can cause considerable anxiety among
people with PD [39]. This suggests that stair climbing should
be considered more speciﬁcally both when assessing and
treating people with PD.
Inadditiontowalkingdiﬃculties,ourprimaryregression
model identiﬁed fatigue, need for help in daily activities,
and ﬂuctuations as additional but relatively minor factors
associated with FOF. Although the contributions were small
(≤2.3% for each of the variables), this is, as far as we know,
the ﬁrst study showing that fatigue and motor ﬂuctuations
may be associated with FOF in PD. These results support the
value of an interdisciplinary approach in the management
of FOF including, for example, an optimization of anti-PD
medications and eﬀorts targeting independence in activities
of daily living.
There are some methodological concerns associated with
this study. All data were self-reported, and future studies
should consider including also clinical tests and assessments
in order to provide a more complete and detailed picture.
For example, “having balance problems when standing or
walking” (item 6, Walk-12G) is a coarse indicator of a
very complex issue. This item does not take into account
the complex interaction between the person, environment
and the activity at hand, and it cannot separate balance
problems in standing from those connected with walking.
Although this study considered a relatively broad variety of
aspects, we acknowledge that there may be additional aspects
inﬂuencing FOF in PD (e.g., cognitive problems, executive
dysfunctions, and environmental factors). In addition, our
sample was relatively limited and drawn from a university
clinic. It is unknown to what extent such a sample is rep-
resentative for the PD population at large, which may
inﬂuence the external validity of our ﬁndings. Finally, the
response rate of 68% may potentially have introduced a
bias, particularly since the study design did not allow for
a thorough analysis of responders versus nonresponders.
However, excluded responders did not diﬀer from those
included with respect to sex, age, and PD duration, and the
prevalence of FOF found here (close to 50%) is in agreement
with that reported in other studies [2, 12–16]. Nevertheless,
in order to gain a deeper understanding and reach ﬁrmer
conclusions, additional quantitative and qualitative work is
needed within this area.
5. Conclusions
This is to our knowledge the ﬁrst study using multivariate
analysis to explore factors associated with FOF in people
with PD. The present results suggest that walking ability
is the primary target in order to reduce FOF. Speciﬁcally,
balance, climbing stairs, and turning seem to be of particular
importance. Additional studies are warranted in order to
further improve our understanding of FOF and how to best
approach it in rehabilitation.
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